Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Completed × ciforadenant × Clear all

Phase

Phase 1 3 Phase 1/2 1

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 111 Paclitaxel 105 Gemcitabine 104 Radiotherapy 98 Carboplatin 93 pembrolizumab 91 Cisplatin 86 Nivolumab 78 Docetaxel 78 Rituximab 70 Lenalidomide 63 Cytarabine 56 Bevacizumab 55 Etoposide 54 Peripheral Blood Stem Cell Transplantation 53 Filgrastim 52 Dexamethasone 52 Capecitabine 51 fludarabine phosphate 50 Fluorouracil 50 Temozolomide 49 Oxaliplatin 46 Irinotecan 46 Everolimus 45 Doxorubicin 45 Cetuximab 45 Prednisone 44 Melphalan 43 Erlotinib Hydrochloride 43 Sorafenib 41

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03337698 2025-12-12

Morpheus Lung

Hoffmann-La Roche

Phase 1/2 Completed

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡